Caplin Point Gets US FDA Approval For Generic Amidate

Caplin Point Gets US FDA Approval For Generic Amidate

By, Admin 26 December 2020

Caplin Point Laboratories Limited has been granted final approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) etomidate injection USP, 20 mg/10 ml (2 mg/ml) and 40 mg/20 ml (2 mg/ml) single-dose vial presentations, a generic therapeutic equivalent version of Amidate (etomidate) injection, of Hospira Inc.Etomidate is a general anesthetic, used for the induction of general anesthesia and for the supplementation of subpotent anesthetic agents.C C Paarthipan, chairman of Caplin Point Laboratories Limited commented "We understand etomidate injection has frequently been on the shortage list in the US, which is probably the reason why we received this approval within 6 months. We hope to launch this product within a short period in the US."The company is also working on a portfolio of 35 simple and complex injectable and ophthalmic products, to be filed over the next 4 years, with an addressable market size of US$ 2.1 billion.According to IQVIA (IMS Health), etomidate injection USP had US sales data of approximately $9 million for the 12-month period ending October 2020.Caplin Steriles Limited, has developed and filed 19 ANDAs on its own and with partners, with 11 approvals so far.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!